FedEx shipping discounts available on campus

Washington University in St. Louis staff and students are eligible for FedEx shipping discounts for personal use at the three campus FedEx Office locations. You must show a valid university ID to use the discount.
Van Engen organizes ‘Religion and Politics in Early America’ conference

Van Engen organizes ‘Religion and Politics in Early America’ conference

Abram C. Van Engen, associate professor of English in Arts & Sciences, organized a national conference on “Religion and Politics in Early America.” Sponsored by the John C. Danforth Center on Religion and Politics and the Kinder Institute on Constitutional Democracy, the conference took place March 1-4 in St. Louis. 
A new view on electron interactions in graphene

A new view on electron interactions in graphene

There’s a new way to look at how electrons interact with each other in graphene, an intriguing material comprised of a single layer of carbon atoms. Washington University in St. Louis researchers, led by Erik Henriksen, assistant professor of physics in Arts & Sciences, are exploring the quantum electronic properties of graphene using infrared light.
Great Artists Series presents Susan Graham March 25

Great Artists Series presents Susan Graham March 25

Opera star Susan Graham, dubbed “America’s favorite mezzo” by Gramophone magazine, will perform “Frauenliebe und-leben: Variations,” a solo recital pairing Robert Schumann’s beloved song cycle with related works by Edvard Grieg, Richard Strauss, Gustav Mahler, Claude Debussy, Pyotr Tchaikovsky and others.
Kolker elevated to AIA College of Fellows

Kolker elevated to AIA College of Fellows

James Kolker, university architect and associate vice chancellor at Washington University in St. Louis, has been elevated to the College of Fellows in the American Institute of Architects, an honor bestowed on only about 3 percent of the organization’s 90,000 members.
CRISPR enhances cancer immunotherapy

CRISPR enhances cancer immunotherapy

Scientists at the School of Medicine have used the gene-editing technology CRISPR to engineer human T cells that can attack human T cell cancers without succumbing to friendly fire. The study evaluating the approach in mice appears online in the journal Leukemia.
View More Stories